Physician profile
Michael C Macdonald
NPI 1235220740
$5,400.19
in general payments reported to CMS, 2019-2025
21 companies · $22.81 in 2025
The $22.81 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $431 · 2021: $275 · 2023: $14.83 · 2024: $4,148 · 2025: $22.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,922 · Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,921.78 |
| Food and Beverage | $263.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midmark Corporation | $4,105.06 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $270.06 | 2019-2021 | |
| Pfizer INC. | $156.62 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $131.09 | 2019-2021 | |
| Glaxosmithkline, LLC. | $126.73 | 2019-2020 | |
| Abbvie INC. | $87.99 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.84 | 2019-2021 | |
| Novo Nordisk INC | $78.88 | 2019-2021 | |
| Astellas Pharma US INC | $66.32 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $42.94 | 2021 | |
| Merck Sharp & Dohme LLC | $39.44 | 2019-2020 | |
| Allergan, INC. | $36.23 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $32.01 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $24.74 | 2020 | |
| Hologic Sales and Service, LLC | $22.81 | 2025 | Thinprep 2000 Processor, Aptima |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.83 | 2024 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $17.47 | 2019 | |
| Nestle Healthcare Nutrition INC. | $16.41 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.72 | 2020 | |
| Sanofi Pasteur INC. | $14.04 | 2019 | |
| Circassia INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Macdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.